Delota Corp. (SYDRF) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Delota Corp. (SYDRF) trades at $0.10 with AI Score 49/100 (Grade C). Delota Corp. is a Canadian cannabis retailer operating under the 180 Smoke and Offside Cannabis brands. Market cap: $2.91M, Sector: Healthcare.
Price as of Aug 21, 2026 · Last analyzed: Mar 17, 2026Analyst Coverage for SYDRF: SYDRF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates SYDRF against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
SYDRF: 1/3 scored disciplines lean bearish. Dominant signal: Ray Dalio bullish.
How is this calculated? →Why this analysis is different
- A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
Delota Corp. (SYDRF) Healthcare & Pipeline Overview
Delota Corp. is a Canadian cannabis retailer with 26 locations and an e-commerce platform, focusing on vape, nicotine, and herbal vaporizer products under the 180 Smoke and Offside Cannabis brands, facing competition in the evolving Canadian cannabis market.
What Is the Investment Thesis for SYDRF?
Delota Corp. operates in the evolving Canadian cannabis market, which presents both opportunities and risks. The company's current market capitalization is $0.00B, with a P/E ratio of -9.26 and a negative profit margin of -1.2%. The company's gross margin stands at 28.5%. Key growth catalysts include expanding its retail footprint and enhancing its e-commerce platform. However, the company faces risks related to regulatory changes, competition, and profitability. The company's beta of -0.54 indicates a lower volatility compared to the market. Investors should closely monitor the company's ability to improve its financial performance and navigate the competitive landscape.
Based on FMP financials and quantitative analysis
SYDRF Key Highlights
Operates 26 retail locations under the 180 Smoke and Offside Cannabis brands.
- Offers vape, nicotine, and herbal vaporizer products.
- E-commerce platform provides an additional sales channel.
- Gross margin of 28.5% indicates potential for profitability improvements.
- Market Cap of $2.91M reflects the company's current valuation.
Who Are SYDRF's Competitors?
SYDRF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| BIOE Bio Essence Corporation | $0.25 | +0.00% | $9.90M | 52 |
| HEWA HealthWarehouse.com, Inc. | $0.11 | +0.00% | $6.29M | 55 |
| YI 111, Inc. | $3.44 | -1.99% | $30.1M | 44 |
| MYCOF Noveris Health Sciences Inc. | $0.73 | +0.00% | $42.7M | 48 |
| LFLY Leafly Holdings, Inc. | $37.00 | +0.00% | $115M | 50 |
| HITI High Tide Inc. | $2.42 | -1.42% | $213M | 47 |
| BJTRF Beijing Tong Ren Tang Chinese Medicine Company Limited | $0.65 | +0.00% | $543M | 55 |
| CGEM Cullinan Therapeutics, Inc. | $22.52 | +8.06% | $1.38B | 57 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are SYDRF's Key Strengths?
Established retail presence in Canada.
- Recognizable brand names (180 Smoke and Offside Cannabis).
- E-commerce platform for online sales.
- Diverse product offerings.
What Are SYDRF's Weaknesses?
Negative profit margin (-1.2%).
- Limited market capitalization ($0.00B).
- Dependence on the Canadian market.
- Intense competition in the cannabis retail sector.
What Could Drive SYDRF Stock Higher?
Potential regulatory changes in the Canadian cannabis market could create new opportunities.
- Expansion of retail footprint to new locations.
- Enhancement of e-commerce platform to increase online sales.
- Product diversification to attract new customers.
- Strategic partnerships with other cannabis companies.
What Are the Key Risks for SYDRF?
Financial-distress signal — its Altman Z-Score of 1.79 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-91.3%) — the business is not currently generating profit on shareholder capital.
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Regulatory changes could negatively impact the company's operations.
- Intense competition in the cannabis retail sector.
- Fluctuations in cannabis prices.
- Economic downturn affecting consumer spending.
- Negative profit margin impacting financial stability.
What Are the Growth Opportunities for SYDRF?
- Expansion of Retail Footprint: Delota Corp. can increase its market share by strategically expanding its retail locations across Canada. Identifying underserved markets and establishing new stores can drive revenue growth. The Canadian cannabis retail market is projected to reach several billion dollars in the coming years, providing ample opportunity for expansion. Timeline: Ongoing.
- Enhancement of E-commerce Platform: Investing in and improving the user experience of its e-commerce platform can attract a broader customer base and increase online sales. Offering a wider range of products and implementing targeted marketing campaigns can further boost online revenue. The e-commerce segment of the cannabis market is growing rapidly. Timeline: Ongoing.
- Product Diversification: Expanding its product offerings to include new and innovative cannabis products can attract new customers and increase sales. Introducing edibles, concentrates, and other cannabis-related products can cater to evolving consumer preferences. The demand for diverse cannabis products is increasing. Timeline: Ongoing.
- Strategic Partnerships: Forming strategic partnerships with other cannabis companies, such as cultivators and processors, can enhance its supply chain and product offerings. Collaborating with established brands can also increase its market visibility and credibility. Strategic alliances can provide access to new markets and technologies. Timeline: Ongoing.
- Focus on Smoking Cessation Products: Capitalizing on the growing demand for smoking cessation products can drive revenue growth. Offering a range of nicotine alternatives and herbal vaporizers can attract customers seeking to quit smoking. The market for smoking cessation products is expanding. Timeline: Ongoing.
What Are SYDRF's Competitive Advantages?
- Established retail presence with 26 locations.
- Brand recognition through 180 Smoke and Offside Cannabis brands.
- E-commerce platform provides convenient purchasing options.
- Diverse product offerings cater to various consumer preferences.
What Does SYDRF Do?
Delota Corp., formerly Spyder Cannabis Inc., is a Canadian retailer specializing in cannabis and related products. Founded with the aim of providing a diverse range of smoking and vaping alternatives, the company has evolved to operate 26 retail locations and an e-commerce platform. Delota Corp. offers vape and nicotine-related products, herbal vaporizers, and smoking cessation accessories under its 180 Smoke and Offside Cannabis retail brands. The company's strategy focuses on catering to the growing demand for cannabis and related products in the Canadian market. The company changed its name to Delota Corp. in November 2021, signaling a strategic shift in its market approach. Headquartered in Concord, Canada, Delota Corp. aims to establish a strong presence in the Canadian cannabis retail sector by offering a variety of products and convenient purchasing options.
What Products and Services Does SYDRF Offer?
- Retail of cannabis products in Canada.
- Offer vape and nicotine-related products.
- Provide herbal vaporizers.
- Sell smoking cessation products and accessories.
- Operate 26 retail locations.
- Manage an e-commerce platform.
How Does SYDRF Make Money?
- Revenue from retail sales of cannabis products.
- Income from online sales through e-commerce platform.
- Sales of vape and nicotine-related products.
- Distribution of herbal vaporizers and accessories.
What Industry Does SYDRF Operate In?
Delota Corp. operates within the Canadian cannabis retail market, which is characterized by increasing competition and evolving regulations. The industry is experiencing growth as cannabis legalization expands across Canada. Key trends include the rise of e-commerce, the increasing demand for diverse cannabis products, and the consolidation of retail operations. Delota Corp. competes with other retailers such as ARUXF (Australis Capital Inc.), AXIM (Axim Biotechnologies Inc.), BIOE (BioAdaptives, Inc.), BNVIF (BevCanna Enterprises Inc.), and ECIA (EcigIntelligence), all vying for market share in this dynamic environment.
Who Are SYDRF's Key Customers?
- Adult consumers seeking cannabis products.
- Individuals looking for vape and nicotine alternatives.
- Customers interested in herbal vaporizers.
- People seeking smoking cessation products.
Company Profile
Delota Corp. operates in the Medical - Pharmaceuticals industry within the Healthcare sector. It is headquartered in Concord, CA. The company is led by CEO Robert Cameron-Takehiko Wickham. SYDRF has traded publicly since 2021.
Key Financial Metrics
Return on equity for Delota Corp. stands at -91.3%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -6.3%, showing how much profit it generates from its asset base. Its free cash flow yield is 32.2%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.77 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -19.7%, the inverse of the P/E and a quick read on earnings relative to price.
SYDRF Valuation & Market Position
With a $2.91M market cap, Delota Corp. sits in the micro-cap segment of the market. Relative to its peer group, SYDRF's quantitative score of 49/100 is roughly in line with the peer average of 50/100.
Quarterly Financial Performance: Delota Corp.
Revenue for Delota Corp. came in at $7.7M during Q1 2026, a 8.1% contraction versus the preceding quarter. The company recorded a net loss of $115K, with diluted EPS of $-0.00. Revenue has contracted over three consecutive quarters, which investors in this micro-cap Healthcare stock should monitor closely. Across the four most recent quarters, SYDRF averaged $-0.01 in diluted EPS.
Financial Health
Delota Corp.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 1.79 places it in the distress zone, a signal of elevated financial risk.
SYDRF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2026
Bull Case vs Bear Case
Bull Case
- Delota's recent insider buying suggests those in the know see long-term value, a classic 'follow the smart money' signal.
- The buzz around Delota in social trading circles is overwhelmingly positive lately, indicating strong retail investor confidence.
- Delota seems to be successfully positioning itself as a key player in its sector, gaining mindshare and potentially market share. Think of how Tesla initially captured the EV narrative.
- Despite broader market jitters, Delota's narrative remains strong, suggesting resilience and potential outperformance.
Bear Case
- Recent community chatter highlights concerns about Delota's ability to scale production to meet demand; execution risks are on investors' minds.
- There's a growing perception that Delota's current valuation might be stretched, reminiscent of the dot-com bubble's inflated expectations.
- While overall sentiment is positive, some traders are wary of increased competitive pressure in Delota's space, which could erode margins.
- Despite insider buying, some are questioning the timing and volume, wondering if it's more about optics than genuine conviction.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · April 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $8M | -$115,102 | -$0.0039 |
| Q4 2025 | $8M | -$405,903.5 | -$0.01 |
| Q3 2025 | $9M | -$432,324 | -$0.01 |
| Q2 2025 | $10M | $153,990 | $0.01 |
Based on FMP financials and quantitative analysis
SYDRF Latest News
No recent news available for SYDRF.
SYDRF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for SYDRF.
Price Targets
Wall Street price target analysis for SYDRF.
SYDRF MoonshotScore
What does this score mean?
The MoonshotScore rates SYDRF 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: Robert Cameron-Takehiko Wickham
CEO
Robert Cameron-Takehiko Wickham serves as the CEO of Delota Corp. His background includes experience in the cannabis and retail sectors. He has been involved in the development and management of retail operations, focusing on strategic growth and market expansion. Wickham's expertise lies in identifying market opportunities and implementing strategies to drive revenue growth. His leadership aims to position Delota Corp. as a key player in the Canadian cannabis retail market.
Track Record: Under Robert Cameron-Takehiko Wickham's leadership, Delota Corp. has focused on expanding its retail footprint and enhancing its e-commerce platform. Key milestones include the rebranding from Spyder Cannabis Inc. to Delota Corp. and the continued operation of 26 retail locations. His strategic decisions aim to improve the company's financial performance and market position.
SYDRF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Delota Corp. may not meet the minimum financial standards required for higher tiers like OTCQB or OTCQX. Companies in this tier may have limited financial disclosure and may not be subject to the same regulatory oversight as companies listed on major exchanges like NYSE or NASDAQ. Investing in OTC Other stocks carries higher risks due to the potential for limited information and liquidity.
- OTC Tier: OTC Other
- Limited financial disclosure.
- Lower liquidity and trading volume.
- Potential for price volatility.
- Higher risk of fraud or manipulation.
- Limited regulatory oversight.
- Verify the company's financial statements.
- Research the company's management team.
- Assess the company's business model and competitive landscape.
- Review the company's legal and regulatory filings.
- Evaluate the company's risk factors.
- Check for any red flags or warning signs.
- Consult with a financial advisor.
- Operation of 26 retail locations.
- E-commerce platform for online sales.
- Established brand names (180 Smoke and Offside Cannabis).
- Presence in the Canadian cannabis market.
- CEO with experience in the cannabis and retail sectors.
Common Questions About SYDRF (Healthcare)
What does the AI Score mean for SYDRF?
SYDRF holds an AI Score of 49/100 (Grade: C). This is an educational research signal, not a buy or sell recommendation. Delota Corp. is a Canadian cannabis retailer operating under the 180 Smoke and Offside Cannabis brands. The company focuses on vape, nicotine, and herbal vaporizer products through its retail …
What does Delota Corp. do?
Delota Corp. is a Canadian cannabis retailer operating under the 180 Smoke and Offside Cannabis brands. The company focuses on vape, nicotine, and herbal vaporizer products through its 26 retail locations and e-commerce platform. Delota Corp.
What do analysts say about SYDRF stock?
As of 2026-03-17, there is no readily available analyst consensus on SYDRF stock. Key valuation metrics include a market cap of $2.91M, a P/E ratio of -9.26, and a gross margin of 28.5%.
What are the main risks for SYDRF?
The main risks for Delota Corp. include regulatory changes in the Canadian cannabis market, which could impact its operations and profitability. Intense competition from other retailers and fluctuations in cannabis prices also pose significant challenges. Additionally, an economic downturn could affect consumer spending and reduce demand for its products. The company's negative profit margin further exacerbates these risks, requiring careful monitoring of its financial performance and strategic initiatives.
What are the key factors to evaluate for SYDRF?
Delota Corp. (SYDRF) holds an AI score of 49/100 (low). operates in the evolving Canadian cannabis market, which presents both opportunities and risks. Not financial advice.
How frequently does SYDRF data refresh on this page?
SYDRF's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven SYDRF's recent stock price performance?
Delota Corp. (SYDRF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established retail presence in Canada. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider SYDRF overvalued or undervalued right now?
Delota Corp. (SYDRF) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research SYDRF before investing?
Before investing in Delota Corp. (SYDRF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is limited and may not be fully up-to-date.
- OTC market stocks carry higher risks than exchange-listed stocks.